# Kiora Pharmaceuticals Inc: Form DEF 14A, filed Aug 8, 2022

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: DEF 14A
- Filed: 2022-08-08
- Accepted by EDGAR: Aug 8, 2022, 16:30 ET
- Period: 2022-09-15
- Accession: 0001104659-22-087273
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000110465922087273/tm2221880-2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000110465922087273/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000110465922087273/tm2221880-2_def14a.htm

Filed Aug 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-087273. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
